Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry


ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

New, Substituted Derivatives of Dicarboximides and their Cytotoxic Properties

Author(s): Bożena Kuran, Mariola Napiórkowska, Jerzy Kossakowski, Marcin Cieślak, Julia Kaźmierczak-Barańska, Karolina Królewska and Barbara Nawrot

Volume 16, Issue 7, 2016

Page: [852 - 864] Pages: 13

DOI: 10.2174/1871520616666160223114318

Price: $65


A large group of aminoalkyl and aminoalkanol derivatives of selected dicarboximides were synthesized and characterized by 1HNMR, 13CNMR and ESI MS spectra analysis. The thirty nine new compounds were tested for their cytotoxic properties in human chronic (K562), acute leukemia (HL-60), and cervical cancer cells (HeLa) as well as in normal endothelial cells (HUVEC). The most promising compounds are 4-[2-(dimethylamino)ethyl]-, (diethylamino) ethyl]-, 4-[2-(piperidin-1-yl)ethyl]-, 4-[3-(dimethylamino)propyl]- and 4-[2-hydroxy-3-(propan- 2-ylamino)propyl]- derivatives of 1,7-diethyl-8,9-diphenyl-4-azatricyclo[,6]dec-8-ene-3,5,10-trione exhibiting high and selective cytotoxicity towards K562 and HL-60 cells (IC50 in the range of 1-10 µM) while being non-toxic towards HUVEC and HeLa cells (IC50> 100 μM). Moreover, the preliminary studies have showed that 4-[2-(piperidin-1-yl)ethyl]- 1,7-diethyl-8,9-diphenyl-4-azatricyclo [,6]dec-8-ene-3,5,10-trione induces programmed cell death (apoptosis) in leukemia cells.

Keywords: Dicarboximides, cytotoxic properties, HeLa, HL-60, K562, apoptosis.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy